HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo.

Abstract
The efficacy of the selective adenosine cyclic 3',5'-monophosphate (cAMP) phosphodiesterase (PDE) inhibitor (+/-)-rolipram and its optical isomers (0.006 to 25 mg kg-1) in inducing characteristic behavioural changes like hypothermia, hypoactivity, forepaw shaking, grooming and head twitches in rats has been examined. (+)-Rolipram was found some 15 times less potent than the racemate suggesting a stereoselective interaction with a rat brain cAMP phosphodiesterase isoenzyme. Following their intracerebral administration, the stereoisomers also demonstrated their unusual potency ratio. These findings suggested that (+)-rolipram is a less potent neurotropic PDE inhibitor in-vivo than its (-)-enantiomer.
AuthorsH Wachtel
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 35 Issue 7 Pg. 440-4 (Jul 1983) ISSN: 0022-3573 [Print] England
PMID6136585 (Publication Type: Journal Article)
Chemical References
  • Pyrrolidinones
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Rolipram
Topics
  • 3',5'-Cyclic-AMP Phosphodiesterases (antagonists & inhibitors)
  • Animals
  • Behavior, Animal (drug effects)
  • Body Temperature (drug effects)
  • Brain (drug effects)
  • Injections, Intraventricular
  • Male
  • Motor Activity (drug effects)
  • Pyrrolidinones (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Rolipram
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: